EurekaMag.com logo
+ Site Statistics
References:
54,215,046
Abstracts:
30,230,908
PMIDs:
28,215,208
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Recurrences of hepatocellular carcinoma following initial remission by transarterial chemo-embolization



Recurrences of hepatocellular carcinoma following initial remission by transarterial chemo-embolization



Hepatology 28(4 PART 2): 229A




(PDF emailed within 1 workday: $29.90)

Accession: 033119073

Download citation: RISBibTeXText



Related references

The efficacy and tolerability of transarterial chemo-embolization (TACE) compared with transarterial embolization (TAE) for patients with unresectable hepatocellular carcinoma (HCC). Journal of Clinical Oncology 26(15_suppl): 4595-4595, 2016

Comparison of transarterial chemo-embolization (TACE) and transarterial radio-embolization (TARE) for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis. Hpb 18: E202-E203, 2016

Transarterial segmental hepatic chemo-embolization in patients with hepatocellular carcinoma. Gan to Kagaku Ryoho. Cancer & ChemoTherapy 15(8 Pt 2): 2540-2543, 1988

Recurrences of hepatocellular carcinoma following complete remission by transarterial chemoembolization or radiofrequency therapy: Focused on the recurrence patterns. Hepatology Research 43(12): 1304-1312, 2013

Therapeutic efficacy of transarterial chemo-embolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma. World Journal of Gastroenterology 19(14): 2242-2248, 2013

Transarterial (chemo)embolization for curative resection of hepatocellular carcinoma: a systematic review and meta-analyses. Journal of Cancer Research and Clinical Oncology 140(7): 1159-1170, 2014

Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. Journal of Gastroenterology & Hepatology 17(1): 52-58, January, 2002

Transarterial embolization for large hepatocellular carcinoma with use of superabsorbent polymer microspheres: initial experience. Journal of Vascular and Interventional Radiology 13(9 Pt 1): 929-934, 2002

Dual-phase cone-beam computed tomography to see, reach, and treat hepatocellular carcinoma during drug-eluting beads transarterial chemo-embolization. Journal of Visualized Experiments 82): 50795-50795, 2014

Minimum ten year extended survival for patients with hepatocellular carcinoma treated by hepatic resection, percutaneous ethanol injection therapy and transarterial chemo-embolization. Hepatology 28(4 PART 2): 337A, 1998

Reactivation of hepatitis B virus after transarterial chemo-embolization for hepatocellular carcinoma in one patient with negative hepatitis B surface antigen. Journal of Hepatology 52(3): 463-465, 2010

Role of assessment for retreatment with Transarterial chemoembolization score in decision of Retreatment with trans-arterial chemo-embolization Sessions in patients with hepatocellular carcinoma. Journal of Ayub Medical College, Abbottabad 29(3): 378-383, 2017

Relative Initial Weight Is Associated with Improved Survival without Altering Tumor Latency in a Translational Rat Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma and Transarterial Embolization. Journal of Vascular and Interventional Radiology 28(7): 1043-1050.E2, 2017

Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma. Journal of Vascular and Interventional Radiology 21(3): 327-332, 2010

Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinoma. Clinical Colorectal Cancer 11(3): 185-190, 2013